{
  "version": 3,
  "sources": ["ssg:https://framerusercontent.com/modules/wQKhJeQUooXeG9mOozNo/CuiLvh3Oi1gtoaEAREq6/hgYIGNl7q.js"],
  "sourcesContent": ["// Generated by Framer (f7ce5cf)\nexport default function metadata(params,activeLocale){return{breakpoints:[{hash:\"49tj52\",mediaQuery:\"(min-width: 1920px)\"},{hash:\"7afrex\",mediaQuery:\"(min-width: 1200px) and (max-width: 1919px)\"},{hash:\"a2s5d6\",mediaQuery:\"(min-width: 810px) and (max-width: 1199px)\"},{hash:\"acbmi8\",mediaQuery:\"(max-width: 809px)\"}],description:\"Converge\u2019s AI maps phenotypes to molecular causes using multiomics data, enabling rare disease diagnosis, targeted therapies, and biomarker-driven trials. This improves precision, reduces trial risk, and accelerates the development of effective treatments\",elements:{},framerSearch:{index:true},robots:\"max-image-preview:large\",serializationId:\"framer-MVOAp\",socialImage:\"https://framerusercontent.com/assets/PRt9wvPPqBZcXYtw0s2VTj4rhU.png\",title:\"Identify New Biomarkerson\",viewport:\"width=device-width\"};}export const metadataVersion=1;\nexport const __FramerMetadata__ = {\"exports\":{\"metadataVersion\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"default\":{\"type\":\"function\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"__FramerMetadata__\":{\"type\":\"variable\"}}}"],
  "mappings": "AACe,SAARA,EAA0BC,EAAOC,EAAa,CAAC,MAAM,CAAC,YAAY,CAAC,CAAC,KAAK,SAAS,WAAW,qBAAqB,EAAE,CAAC,KAAK,SAAS,WAAW,6CAA6C,EAAE,CAAC,KAAK,SAAS,WAAW,4CAA4C,EAAE,CAAC,KAAK,SAAS,WAAW,oBAAoB,CAAC,EAAE,YAAY,uQAAkQ,SAAS,CAAC,EAAE,aAAa,CAAC,MAAM,EAAI,EAAE,OAAO,0BAA0B,gBAAgB,eAAe,YAAY,sEAAsE,MAAM,4BAA4B,SAAS,oBAAoB,CAAE,CAAQ,IAAMC,EAAgB,EACr1BC,EAAqB,CAAC,QAAU,CAAC,gBAAkB,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,QAAU,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,mBAAqB,CAAC,KAAO,UAAU,CAAC,CAAC",
  "names": ["metadata", "params", "activeLocale", "metadataVersion", "__FramerMetadata__"]
}